{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:36:05Z","timestamp":1786703765678,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To describe the epidemiology of blood cultures (BCs) drawn from patients with suspected sepsis by a rural ambulance service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients were included if they had clinically suspected sepsis and at least one BC was drawn. Variables associated with positive BCs were identified with logistic regression, culture results before and after ambulance antimicrobial therapy were compared and the susceptibility to empirical antimicrobial therapy in bacterial isolates was determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 392 included patients, sepsis severity score were higher when BCs were positive than negative, but there was no significant difference in 30-day all-cause mortality between BC negative and positive patients. In 47 patients ambulance blood cultures were positive (47\/347 (13,5%)). Fever (OR 1.54, 95% CI 1.11\u20132.15) was associated with higher odds of positive cultures, while lower respiratory tract infection was associated with lower odds of positive cultures (OR 0.10, 95% CI 0.04\u20130.30). In 205 patients who had both ambulance and hospital BCs drawn and received ambulance antimicrobial therapy, only the ambulance BCs were positive in 16 patients, whereas in 4 patients only hospital cultures were positive. Bacterial isolates from positive BCs were susceptible to the empirical antimicrobial regimen in 80% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Positive ambulance BCs were associated with higher sepsis severity, and ambulance cultures were most useful in febrile patients with a suspected focus of infection other than the lower airways. Repeated BCs after hospital admission added only limited diagnostic value if an adequate ambulance BC had already been drawn.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-026-02830-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:16:38Z","timestamp":1779441398000},"page":"2011-2018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4778-3156","authenticated-orcid":false,"given":"Lars-J\u00f8ran","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-7045","authenticated-orcid":false,"given":"Gunnar Skov","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-3580","authenticated-orcid":false,"given":"Erik","family":"Sollig\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-8007","authenticated-orcid":false,"given":"Knut","family":"Fredriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"8","key":"2830_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"2830_CR2","first-page":"ii11","volume":"66","author":"R Daniels","year":"2011","unstructured":"Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist\u2019s perspective). J Antimicrob Chemother. 2011;66(Suppl 2):ii11\u201323.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2830_CR3","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"8","key":"2830_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749\u201355.","journal-title":"Crit Care Med"},{"issue":"1","key":"2830_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2213-2600(17)30469-1","volume":"6","author":"N Alam","year":"2018","unstructured":"Alam N, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6(1):40\u201350.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2830_CR6","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1186\/s12913-024-11827-x","volume":"24","author":"L-J Andersson","year":"2024","unstructured":"Andersson L-J, et al. Timely empirical antibiotic therapy against sepsis in a rural Norwegian ambulance service: a prospective cohort study. BMC Health Serv Res. 2024;24(1):1320.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2830_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","volume":"40","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Intensive Care Med. 2014;40(1):32\u201340.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2830_CR8","doi-asserted-by":"publisher","first-page":"e0214052","DOI":"10.1371\/journal.pone.0214052","volume":"14","author":"RS Nannan Panday","year":"2019","unstructured":"Nannan Panday RS, et al. Evaluation of blood culture epidemiology and efficiency in a large European teaching hospital. PLoS ONE. 2019;14(3):e0214052.","journal-title":"PLoS ONE"},{"issue":"5","key":"2830_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/jama.2012.8262","volume":"308","author":"B Coburn","year":"2012","unstructured":"Coburn B, et al. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308(5):502\u201311.","journal-title":"JAMA"},{"issue":"4","key":"2830_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1684-1182(10)60054-0","volume":"43","author":"ML Towns","year":"2010","unstructured":"Towns ML, Jarvis WR, Hsueh PR. Guidelines on blood cultures. J Microbiol Immunol Infect. 2010;43(4):347\u20139.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"2830_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/aas.13777","volume":"65","author":"VS Mikkelsen","year":"2021","unstructured":"Mikkelsen VS, et al. Pre-hospital antibiotic therapy preceded by blood cultures in a physician-manned mobile emergency care unit. Acta Anaesthesiol Scand. 2021;65(4):540\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"2830_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10903127.2016.1254694","volume":"21","author":"JG Walchok","year":"2017","unstructured":"Walchok JG, et al. Paramedic-Initiated CMS Sepsis Core Measure Bundle Prior to Hospital Arrival: A Stepwise Approach. Prehosp Emerg Care. 2017;21(3):291\u2013300.","journal-title":"Prehosp Emerg Care"},{"issue":"1","key":"2830_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13054-019-2431-8","volume":"23","author":"RS Nannan Panday","year":"2019","unstructured":"Nannan Panday RS, et al. An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit Care. 2019;23(1):182.","journal-title":"Crit Care"},{"issue":"11","key":"2830_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"6","key":"2830_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jemermed.2008.04.003","volume":"40","author":"BR Widgren","year":"2011","unstructured":"Widgren BR, Jourak M. Medical Emergency Triage and Treatment System (METTS): a new protocol in primary triage and secondary priority decision in emergency medicine. J Emerg Med. 2011;40(6):623\u20138.","journal-title":"J Emerg Med"},{"key":"2830_CR16","unstructured":"The Norwegian Directorate of Healthhttps:\/\/www.helsedirektoratet.no\/retningslinjer\/antibiotika-i-primaerhelsetjenesten (In Norwegian) Accessed 2025-10-10."},{"key":"2830_CR17","unstructured":"University Hospital of North Norway. Pr\u00f8vetaking av blodkultur (Blood culture sampling). https:\/\/www.youtube.com\/watch?v=NVAkVyj1MUA"},{"issue":"1","key":"2830_CR18","doi-asserted-by":"publisher","first-page":"18586","DOI":"10.1038\/s41598-021-97979-w","volume":"11","author":"J Jones","year":"2021","unstructured":"Jones J, et al. Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Sci Rep. 2021;11(1):18586.","journal-title":"Sci Rep"},{"issue":"2","key":"2830_CR19","doi-asserted-by":"publisher","first-page":"e70027","DOI":"10.1111\/1742-6723.70027","volume":"37","author":"D Cudini","year":"2025","unstructured":"Cudini D, et al. Blood culture collection and administration of intravenous ceftriaxone by paramedics in patients with suspected sepsis (the pass trial). Emerg Med Australas. 2025;37(2):e70027.","journal-title":"Emerg Med Australas"},{"issue":"4","key":"2830_CR20","doi-asserted-by":"publisher","first-page":"e0008724","DOI":"10.1128\/cmr.00087-24","volume":"37","author":"RL Sautter","year":"2024","unstructured":"Sautter RL, et al. American Society for Microbiology evidence-based laboratory medicine practice guidelines to reduce blood culture contamination rates: a systematic review and meta-analysis. Clin Microbiol Rev. 2024;37(4):e0008724.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2830_CR21","doi-asserted-by":"publisher","first-page":"e29766","DOI":"10.5812\/jjm.29766","volume":"9","author":"M Altindis","year":"2016","unstructured":"Altindis M, et al. A Multicenter Evaluation of Blood Culture Practices, Contamination Rates, and the Distribution of Causative Bacteria. Jundishapur J Microbiol. 2016;9(1):e29766.","journal-title":"Jundishapur J Microbiol"},{"issue":"9","key":"2830_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cmi.2018.03.030","volume":"24","author":"S Darg\u00e8re","year":"2018","unstructured":"Darg\u00e8re S, Cormier H, Verdon R. Contaminants in blood cultures: importance, implications, interpretation and prevention. Clin Microbiol Infect. 2018;24(9):964\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"2830_CR23","doi-asserted-by":"publisher","first-page":"R202","DOI":"10.1186\/cc12896","volume":"17","author":"J Phua","year":"2013","unstructured":"Phua J, et al. Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013;17(5):R202.","journal-title":"Crit Care"},{"issue":"6","key":"2830_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.chest.2016.08.1460","volume":"150","author":"S Gupta","year":"2016","unstructured":"Gupta S, et al. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. Chest. 2016;150(6):1251\u20139.","journal-title":"Chest"},{"issue":"4","key":"2830_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/CCM.0000000000002924","volume":"46","author":"S Kethireddy","year":"2018","unstructured":"Kethireddy S, et al. Culture-Negative Septic Shock Compared With Culture-Positive Septic Shock: A Retrospective Cohort Study. Crit Care Med. 2018;46(4):506\u201312.","journal-title":"Crit Care Med"},{"issue":"1","key":"2830_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12873-025-01177-0","volume":"25","author":"LM von Beck","year":"2025","unstructured":"von Beck LM, et al. Empiric antibiotic therapy resistance and mortality in emergency department patients with bloodstream infection: a retrospective cohort study. BMC Emerg Med. 2025;25(1):18.","journal-title":"BMC Emerg Med"},{"key":"2830_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajem.2021.12.062","volume":"53","author":"R Jouffroy","year":"2022","unstructured":"Jouffroy R, et al. Adequacy of probabilistic prehospital antibiotic therapy for septic shock. Am J Emerg Med. 2022;53:80\u20135.","journal-title":"Am J Emerg Med"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02830-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02830-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:10:11Z","timestamp":1786702211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02830-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02830-x","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ambulance quality register was approved by the data protection officer at UNN. The Regional Committee for Medical and Health Research Ethics Northern Norway approved the present study (application number 685406).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all surviving individual participants included in the study. All surviving patients received written information about the study and how to withdraw consent by writing, telephone, or e-mail.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}